Compare Pfizer Inc (PFE) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs ProShares UltraPro QQQ ETF — how do they compare? Pfizer Inc trades at $28.28 (market cap $158.56B), while ProShares UltraPro QQQ ETF trades at $81.28 (market cap $38.74B). The key difference: Pfizer Inc is far larger — about 4.1× ProShares UltraPro QQQ ETF's market cap, and Pfizer Inc pays a 6.18% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and ProShares UltraPro QQQ ETF for 24 Days on average.
| PFE | TQQQ | |
|---|---|---|
Market Cap | $158.56B | $38.74B |
Volume | 44,138,282 | 65,384,797 |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.02 | $87.22 |
52-Week Low | $23.67 | $37.89 |
Typical Hold Time | 158 Days | 24 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, down 0.64% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company reported revenue of $62.58B in 2025 with a net income margin of 6.8%, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, positioning for a catalyst-rich 2026.
The stock presents a value opportunity with a forward P/E of 36.61 and consensus price target of $29.17, but faces risks from patent cliffs and volatile cash flows. Analyst sentiment is mixed with 40% buy ratings, while institutional outlook remains cautious amid earnings pressure and competitive threats in the pharma sector.
TQQQ is trading at $80.22, down 4.04% over the past 24 hours amid mixed technical signals. The ETF maintains a bullish overall technical rating with strong moving average support but faces neutral oscillators and selling pressure in short-term indicators. Recent news highlights significant hidden costs beyond the stated 0.82% expense ratio, including financing charges that impact long-term returns.
The leveraged structure amplifies both gains and losses, creating substantial volatility risk. While technical indicators suggest medium-term bullish potential, the high costs and volatility decay present significant headwinds for long-term investors. Current market sentiment remains cautious despite recent institutional positioning changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
